Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis. (2022)

First Author: Innes H
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.14309/ctg.0000000000000462

PubMed Identifier: 35142723

Publication URI: http://europepmc.org/abstract/MED/35142723

Type: Journal Article/Review

Volume: 13

Parent Publication: Clinical and translational gastroenterology

Issue: 3

ISSN: 2155-384X